Prins, Jan M.

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,662

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,229

Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.

Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2016) · JAMA

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 1,431

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science

Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research

Cited by 408

Surgical Excision versus Antibiotic Treatment for Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Multicenter, Randomized, Controlled Trial

Lindeboom, J. A., Kuijper, E. J., Bruijnesteijn van Coppenraet, E. S., Lindeboom, R., & Prins, J. M. (2007) · Clinical Infectious Diseases

Mycobacterium research and diagnosisTuberculosis Research and Epidemiology

Cited by 245

Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.

Richel, O., de Vries, H. J., van Noesel, C. J., Dijkgraaf, M. G., & Prins, J. M. (2013) · The Lancet Oncology

Colorectal and Anal CarcinomasCervical Cancer and HPV Research

Cited by 181

Which adherence measure – self‐report, clinician recorded or pharmacy refill – is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?

Mekuria, L. A., Prins, J. M., Yalew, A. W., Sprangers, M. A. G., & Nieuwkerk, P. T. (2016) · Tropical Medicine & International Health

HIV/AIDS Research and InterventionsMedication Adherence and Compliance

Cited by 41

Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case–control study

Rottier, W. C., van Werkhoven, C. H., Bamberg, Y. R. P., Dorigo-Zetsma, J. W., van de Garde, E. M., van Hees, B. C., Kluytmans, J. A. J. W., Kuck, E. M., van der Linden, P. D., Prins, J. M., et al. (2018) · Clinical Microbiology and Infection

Antibiotic Resistance in BacteriaAntibiotic Use and Resistance

Cited by 22